Revance Therapeutics, Inc. Uncategorized Contracts & Agreements

15 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Offer Letter dated February 21, 2023 by and between Revance Therapeutics, Inc. and Erica Jordan
Revance Therapeutics, Inc.
Pharmaceuticals
2024
Offer Letter dated September 29, 2022 by and between Revance Therapeutics, Inc. and David Hollander, MD
Revance Therapeutics, Inc.
Pharmaceuticals
2024
Revance Therapeutics, Inc. 202
Revance Therapeutics, Inc.
Pharmaceuticals
2024
Description of Registrants Securities
Revance Therapeutics, Inc.
Pharmaceuticals
2024
Revance Therapeutics, Inc. 202
Revance Therapeutics, Inc.
Pharmaceuticals
2023
Description of Registrants Securities
Revance Therapeutics, Inc.
Pharmaceuticals
2023
Description of Registrants Securities
Revance Therapeutics, Inc.
Pharmaceuticals
2022
Description of Registrants Securities
Revance Therapeutics, Inc.
Pharmaceuticals
2021
Revance Therapeutics, Inc. Amended and Restated 2014 Inducement Plan
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2020
Form of Lock-Up Agreement by and between Revance Therapeutics, Inc. and each of the parties named in each agreement therein
Revance Therapeutics, Inc.
Pharmaceuticals
2020
Description of Registrants Securities
Revance Therapeutics, Inc.
Pharmaceuticals
2020
Appendix A
Revance Therapeutics, Inc.
Pharmaceuticals
2015
Appendix A
Revance Therapeutics, Inc.
Pharmaceuticals
2014
INDEMNITY AGREEMENT [For Officers and Directors Not Affiliated withFunds]
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2014
INDEMNITY AGREEMENT
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2013